These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24821862)

  • 1. Five things to know about...dry eye disease.
    Sharma RA; Mather R
    CMAJ; 2014 Oct; 186(14):1090. PubMed ID: 24821862
    [No Abstract]   [Full Text] [Related]  

  • 2. [Conservative treatment of dry eye].
    Hefner J; Reinshagen H
    Klin Monbl Augenheilkd; 2014 Nov; 231(11):1093-6. PubMed ID: 25275793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reflection on tears and treatments.
    Foulks GN
    Ocul Surf; 2008 Oct; 6(4):151. PubMed ID: 18827946
    [No Abstract]   [Full Text] [Related]  

  • 4. Characteristics of symptoms experienced by persons with dry eye disease while driving in China.
    Wang Y; Lv H; Liu Y; Jiang X; Zhang M; Li X; Wang W
    Eye (Lond); 2017 Nov; 31(11):1550-1555. PubMed ID: 28622318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of modification of the osmolarity in graft versus host disease.
    García-Delpech S; Hervás Ontiveros A; Soler M; Udaondo P; Cisneros-Lanuza Á
    Arch Soc Esp Oftalmol; 2015 Aug; 90(8):401-2. PubMed ID: 25817964
    [No Abstract]   [Full Text] [Related]  

  • 6. Dry Eye.
    Clayton JA
    N Engl J Med; 2018 Jun; 378(23):2212-2223. PubMed ID: 29874529
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of objective optical quality measured by double-pass aberrometry in patients with moderate dry eye: Normal saline vs. artificial tears: A pilot study].
    Vandermeer G; Chamy Y; Pisella PJ
    J Fr Ophtalmol; 2018 Mar; 41(3):238-245. PubMed ID: 29573863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of objective optical quality measured by double-pass aberrometry in patients with moderate dry eye: Normal saline vs. artificial tears: A pilot study.
    Vandermeer G; Chamy Y; Pisella PJ
    J Fr Ophtalmol; 2018 Feb; 41(2):e51-e57. PubMed ID: 29366588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment and management of dry eye disease.
    Buckley RJ
    Eye (Lond); 2018 Feb; 32(2):200-203. PubMed ID: 29303149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of artificial tear treatment on corneal epithelial thickness and corneal topography findings in dry eye patients.
    Çakır B; Doğan E; Çelik E; Babashli T; Uçak T; Alagöz G
    J Fr Ophtalmol; 2018 May; 41(5):407-411. PubMed ID: 29776765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescein-tear breakup time as an assessment of efficacy of tear replacement therapy in dry eye patients: a systematic review and meta-analysis.
    Doughty MJ
    Ocul Surf; 2014 Apr; 12(2):100-11. PubMed ID: 24725322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergan's Mohawk evergreening patent deal draws criticism, but ultimately may flop.
    von Schaper E
    Nat Biotechnol; 2017 Nov; 35(11):1002. PubMed ID: 29121010
    [No Abstract]   [Full Text] [Related]  

  • 13. Over the counter (OTC) artificial tear drops for dry eye syndrome: A Cochrane review summary.
    van der Westhuizen L; Pucker AD
    Int J Nurs Stud; 2017 Jun; 71():153-154. PubMed ID: 28237389
    [No Abstract]   [Full Text] [Related]  

  • 14. ASSESSMENT OF FUNCTIONAL CHANGES TEAR PRODUCTION UNDER THE ACTION OF THE EYE DROPS ON THE BASE OF NATURAL MOLECULE OF ECTOINE AND ARTIFICIAL TEARS IN PATIENTS WITH DRY EYE SYNDROME ON THE BACKGROUND OF ENDOCRINE OPHTHALMOPATHY.
    Veselovskaya NN; Zherebko IB
    Fiziol Zh (1994); 2016; 62(6):118-121. PubMed ID: 29762980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of an oil-based lubricant eyedrop in dry eye patients with lipid deficiency.
    Baudouin C; Galarreta DJ; Mrukwa-Kominek E; Böhringer D; Maurino V; Guillon M; Rossi GC; Van der Meulen IJ; Ogundele A; Labetoulle M
    Eur J Ophthalmol; 2017 Mar; 27(2):122-128. PubMed ID: 27791253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for 24-hour management of dry eye disease: A review.
    Guillon M; Shah S
    Cont Lens Anterior Eye; 2019 Apr; 42(2):147-154. PubMed ID: 30497903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Diquafosol Ophthalmic Solution on Quality of Life in Dry Eye Assessed Using the Dry Eye-Related Quality-of-Life Score Questionnaire: Effectiveness in Patients While Reading and Using Visual Display Terminals.
    Utsunomiya T; Kawahara A; Hanada K; Yoshida A
    Cornea; 2017 Aug; 36(8):908-914. PubMed ID: 28542084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autologous serum tears: Long-term treatment in dry eye syndrome].
    Beylerian M; Lazaro M; Magalon J; Veran J; Darque A; Grimaud F; Stolowy N; Beylerian H; Sabatier F; Hoffart L
    J Fr Ophtalmol; 2018 Mar; 41(3):246-254. PubMed ID: 29602451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prominent corneal nerves, conjunctival neuromas, and dry eye in a patient without MEN2B.
    Lekhanont K; Sontichai V; Bunnapradist P
    Can J Ophthalmol; 2019 Dec; 54(6):e313-e317. PubMed ID: 31836125
    [No Abstract]   [Full Text] [Related]  

  • 20. The pathophysiology, diagnosis, and treatment of dry eye disease.
    Messmer EM
    Dtsch Arztebl Int; 2015 Jan; 112(5):71-81; quiz 82. PubMed ID: 25686388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.